Paramount Acquisition Corp. is an affiliate of Paramount BioSciences, LLC, which focuses primarily on the development of promising in-licensed drug candidates. Founded in 1991 by Lindsay A. Rosenwald, M.D., Paramount BioSciences is a unique drug development and health care financial company that, with the assistance of its affiliated life sciences merchant bank, has created approximately 50 start-up companies over the past fifteen years, about half of those over the past four years alone. Since its inception, Paramount BioSciences and its affiliated companies have been involved in the clinical development of more than seventy drug candidates -- several of which have reached the market -- and have over forty compounds in clinical development today. Paramount BioSciences has extensive experience in all facets of the development of emerging life sciences companies and provides its portfolio companies a wide range of professional and financial support services.
Cautionary Statements
This press release contains forward-looking statements about Paramount,
Chem Rx and their combined business after completion of the proposed
business combination. Forward-looking statements are statements that are
not historical facts. Such forward-looking statements are based upon the
current beliefs and expectations of Paramount's management and are subject
to risks and uncertainties that could cause actual results to differ from
the forward- looking statements. The following factors, among others, could
cause actual results to differ from those set forth in the forward-looking
statements: compliance with government regulations; changes in legislation
or regulatory environments; requirements or changes adversely affecting the
health care industry
'/>"/>
| SOURCE Paramount Acquisition Corp. Copyright©2007 PR Newswire. All rights reserved |